Nectar Lifesciences Limited has issued a notice regarding an upcoming Board of Directors meeting scheduled for Saturday, November 14, 2026. The disclosure is made pursuant to Regulations 29, 30, 33 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The primary agenda for the board meeting includes consideration and approval of the Unaudited Financial Results for the quarter ended September 30, 2026, along with matters related thereto. The notice specifies that this is among other items to be discussed ("inter alia amongst other items").
The notice was addressed to both National Stock Exchange of India Limited (Symbol: NECLIFE) and BSE Limited (Scrip Code: 532649). The document was signed by Sanjaymohan Singh Rawat, Company Secretary & Compliance Officer, on November 06, 2026, at 12:11:48 IST.
Company reference number: NLL/CS/2026-747
Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA